Dexmedetomidine versus Lignocaine in the Prevention of Etomidate-induced Myoclonus- A Randomised Double-blinded Study
Introduction: Etomidate is a preferred induction agent owing to its stable haemodynamic profile, minimal respiratory side-effects, minimal histamine release, cerebral protection and its property of rapid onset and short duration. However, myoclonus has been reported as one of its side-effects which...
Main Authors: | Gojendra Rajkumar, N Shammy, Rupendra Singh Thokchom, Takhelmayum Hemjit Singh, M Dhayanithy, Konjengbam Reshmi Devi, M Anish, Merlin Maritata Loving |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-02-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/17439/60034_CE[Ra1]_F(IS)_PF1(AKA_OM)_PFA(NC)_PN(SS).pdf |
Similar Items
-
Effect of dexmedetomidine in preventing etomidate-induced myoclonus: a meta-analysis
by: Du X, et al.
Published: (2017-02-01) -
Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine
by: H.F. Luan, et al.
Published: (2014-10-01) -
Comparison of different doses of intravenous lignocaine on etomidate-induced myoclonus: A prospective randomised and placebo-controlled study
by: Priyanka Gupta, et al.
Published: (2018-01-01) -
Effect of dexmedetomidine on etomidate-induced myoclonus: a randomized, double-blind controlled trial
by: Miao S, et al.
Published: (2019-05-01) -
To study the effect of three different doses of dexmedetomidine as premedication on the incidence and severity of etomidate-induced myoclonus
by: Ketki Kaushal, et al.
Published: (2023-01-01)